We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection

By LabMedica International staff writers
Posted on 08 Apr 2025

Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. More...

While traditional detection methods are effective, they often lack the ability to provide spatiotemporal data on the release of viral genome material. In a significant breakthrough, researchers have developed a novel, label-free ratiometric fluorosensor that selectively and sensitively detects enteroviral RNA. This advancement paves the way for even more efficient detection methods and highlights the importance of interdisciplinary collaboration in addressing global health challenges.

Fluorescent nanoparticles have become powerful tools in bioanalyte sensing, with carbon dots (CDs) leading the charge due to their ease of synthesis, remarkable photostability, tunable photoluminescence, excellent solubility in water, biocompatibility, and versatile surface functionalities for ligand conjugation. These properties make CDs a transformative force in biosensing. At the Nanoscience Center (NSC) at the University of Jyväskylä (Jyväskylä, Finland), researchers have developed an enhanced ratiometric fluorosensor by functionalizing CDs with a Probe (a single-stranded complementary oligonucleotide fragment) and ethidium bromide (EB) for detecting enteroviral RNA. This effort, combining expertise in biology, chemistry, and physics, represents a significant advancement in viral detection technology.

The newly developed Functionalized Sensor (Func Sensor), where the CDs are covalently bonded with the probe, outperforms the traditional Non-Functionalized Sensor (Non-Func Sensor), which is a simple mix of CDs, the probe, and EB. In both sensor types, the target DNA enhances EB fluorescence upon hybridizing with the probe, while the CDs' fluorescence changes slightly due to electron transfer, enabling ratiometric detection. The Non-Func Sensor showed lower sensitivity to target DNA and was ineffective with actual enteroviral RNA samples. In contrast, the Func Sensor demonstrated much higher sensitivity to both DNA and real viral RNA, showing improved selectivity. The improved performance of the Func Sensor is attributed to enhanced charge transfer facilitated by the covalent functionalization of the CDs.

The proof-of-principle study, published in CARBON, emphasizes the significance of covalently immobilizing the probe to improve electron transfer between the CDs and EB, thereby enhancing performance. This research also demonstrates the Func Sensor’s suitability for practical applications in rapid, real-time, and precise in situ detection of viral RNA. Specifically, the study shows that the Func Sensor can detect enteroviral RNA release from the capsid in real time in vitro. This capability positions the Func Sensor as a novel platform for detecting viral RNA during infection, offering a critical advancement in real-time viral RNA detection. The team’s pioneering work not only provides a new method for viral RNA detection but also contributes valuable insights into charge transfer mechanisms between fluorophores. Building on this success, the team is now working to improve the system’s robustness by replacing the potentially harmful ethidium bromide with safer, less cytotoxic, or biocompatible dyes, further enhancing the safety and effectiveness of in vivo viral RNA detection.

Related Links:
University of Jyväskylä


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The SimpleScreen CRC platform uses multiomics, AI, and machine learning to analyze blood-based signals and detect cancer-associated patterns (Photo courtesy of Freenome)

Blood Test Achieves Improved Detection of Advanced Precancerous Colorectal Lesions

Colorectal cancer is the second-leading cause of cancer-related death in the United States, yet screening uptake remains suboptimal. More than 50 million eligible adults are not up to date with recommended... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.